Understand Abbott (ABT) as a “recurring-revenue company embedded in everyday life and clinical settings”: from strengths and deceleration to less visible vulnerabilities
This is a comprehensive investment analysis note that assesses ABT’s (ABT) growth potential through the lens of structural changes in the AI era and clarifies the company’s relative fundamental positioning by comparing it with competitors, the market, and its own historical performance. It systematically organizes the full range of perspectives investors need, including why the company appears poised to grow and what risks it faces.